key: cord-0725173-3n2kocy7
authors: Polly, Matheus; de Almeida, Bianca L.; Lennon, Robert P.; Cortês, Marina Farrel; Costa, Silvia F.; Guimarães, Thais
title: Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
date: 2021-09-23
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2021.09.018
sha: 8f54490bff636ae879eac681f2038deab269f6f2
doc_id: 725173
cord_uid: 3n2kocy7

BACKGROUND: The impact of COVID-19 on healthcare- associated infections (HCAI) caused by multidrug-resistant (MDR) bacteria that contribute to higher mortality is a growing area of study METHODS: This retrospective observational study compares the incidence density (ID) of HCAI caused by MDR bacteria (CRE, CRAB, CRP, MRSA and VRE) pre-COVID (2017-2019) and during the COVID-19 pandemic (2020) in overall hospitalized patients and in intensive care (ICU) units. RESULTS: We identified 8,869 HCAI, of which 2,641 (29.7%) were caused by bacterial MDR, and 1,257 (14.1%) were from ICUs. The overall ID of MDR infections increased 23% (p<0.005) during COVID-19. The overall per-pathogen analysis shows significant increases in infections by CRAB and MRSA (+108.1%, p&lt;0.005; +94.7%, p&lt;0.005, respectively), but not in CRE, CRP, or VRE. In the ICU, the overall ID of MDR infections decreased during COVID, but that decline was not significant (-6.5%, p=0.26). The ICU per-pathogen analysis of ID of infection showed significant increases in CRAB and MRSA (+42.0%, p=0.001; +46.2%, p=0.04), significant decreases in CRE and CRP (-26.4%, p=0.002; -44.2%, p=0.003, respectively) and no change in VRE. CONCLUSIONS: The COVID-19 pandemic correlates to an increase in ID of CRAB and MRSA both in ICU and non-ICU setting, and a decrease in ID of CRE and CRP in the ICU setting. Infection control teams should be aware of possible outbreaks of CRAB and MRSA and promote rigorous adherence to infection control measures as practices change to accommodate changes in healthcare needs during and after the pandemic.

related to pandemic management, the secondary health effects of the pandemic [2] , the effects of the disease itself [3] , and now evolving mutations of SARS-CoV-2 [4] . To protect patients and healthcare workers, hospitals and clinics implemented various measures to prevent contagion spread, such as the universal use of personal protective equipment (PPE), extensive training, and intensification of existing infection control policies. As the pandemic continues, these combined stresses have pushed many health systems to the limits of their functioning, threatening healthcare system collapse in addition to the unequivocal social and economic devastation that are emerging from this global crisis [5] .

During past pandemics and in outbreaks of respiratory viruses, secondary bacterial and fungal infections were common causes of overall morbidity and mortality, but the impact of these secondary infections during COVID-19 remains under study. [6] [7] Some studies report that 14-44% of patients develop secondary infection, which certainly contributes to worse clinical outcomes, longer hospital stays and higher mortality rates. [6] [7] However, other studies suggest the actual rate of co-infection is relatively low at 3.5%, and the rate of secondary infection in hospitalized patients is 14.3%. Regardless of the actual rates of co-infection and secondary infection, antibiotics are almost certainly overprescribed, with an estimated prevalence of 74.6% in one meta-analysis. With long hospital stays and prolonged mechanical ventilation for some COVID-19 patients, healthcare-associated infections (HCAI) rates have increased, with an associated increase on infections by multidrug resistant (MDR) pathogens. [5] Treatment for real and feared co-infection and HCAI have all contributed to a substantial increase in antibiotic prescribing globally, often using broad-spectrum antimicrobials. [5, 8, 11] This, in turn, is associated with a major impact on the emergence of MDR bacterial infections worldwide [6] [7] [8] [9] invasive support measures and continuous use of PPE will have a measurable impact on the overall incidence of MDR bacterial infections. The objective of this study is to assess the impact of the COVID-19 pandemic on the incidence of MDR bacterial infections in an acute care hospital in Brazil.

We performed an observational retrospective study to identify the incidence of all MDR bacterial infections from January-2017 to December-2020 at Instituto Central and analyzed all cases of HCAI caused by MDR bacteria. For detailed analysis, we also identified HCAI caused by any of these MDR bacteria: carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRP), carbapenem-resistant Acinetobacter baumannii (CRAB), vancomycin-resistant Enterococcus (VRE), or methicillin-resistant Staphylococcus aureus (MRSA).

The rates of MDR bacterial infections are expressed in incidence density (ID) (Although we are prospectively collecting data to complete a time-series analysis of MDR infections when the pandemic concludes, to inform policy in the interim, in this study we look at median incidence change from baseline). The incidence density of infections caused by multidrugresistant bacteria was calculated using the number of MDR infection cases in the period as numerator and the number of patient-days in the same period multiplied by 1,000 as denominator. In order to assess the trend curve, the incidence densities were aggregated for each 3-month period (quarters). To assess pre-and post-pandemic differences, the incidence densities were aggregated from the 2017 to 2019 (pre-pandemic) period and compared with the aggregated data from 2020 (the pandemic period). We analyzed total rates, rates per pathogen and rates of ICU units. In total rates are included the rates of ICUs.

Instituto Central is a tertiary care public teaching hospital affiliated with the Hospital das The incidence densities of infections were analyzed by quarters in all units and in the intensive care units to analyze trends. To analyze the differences between the pre-pandemic and pandemic periods, we used aggregated data and a comparison was made using the Mann-Whitney U test comparing medians in the two periods. A value of p ≤ 0.05 was considered statistically significant. The statistical analysis was performed using the statistical software Epi Info TM version 7.2 of the Centers for Diseases Control.

The study was approved by the ethics committee of the hospital under protocol number 4.414.708.

During the period of study, we identified 8,869 HCAI in our database; 5,143 (57.9%) were caused by one of the appointed bacterial agents and 2,641 (29.7%) were multidrug resistant and were selected for the analysis (as shown in Figure 1 ). Of these, 1,257 (14.1%) were from patients located in the intensive care unit. (See Table 1 .)

There is no statistical difference in incidence between 2017 and 2018, 2018 and 2019, or 2017 and 2019 (unpaired two tailed t-test to 95% confidence, p=0.962, 0.156, and 0.207, respectively; combined simple linear regression trendline R^2=0.233). Hence, the combined data from 2017 to 2019 serves as an appropriate baseline for incidence of MDR infections.

When we analyze the incidence density per year, we can note that the overall incidence density remained stable during the years 2017 to 2020, but when we analyzed the incidence density only in intensive care units, we noticed a decline ( Figure 2 ). Although the increase in MDR incidence between baseline years (2017-19) and the pandemic year (2020) is not significant (6 versus 8.4, p=0.063), the difference between the baseline years and the peak of the pandemic (2 nd and 3 rd trimesters, 2020) is significant (6 versus 11.4, p<0.001). This is easily visualized in Figures 2 and 3 . When the incidence of MDR is considered only in the ICU setting, there is a decrease in incidence from 9.2 to 8.6, but this is not significant (p>0.05). Analysis by MDR pathogens in overall units shows an increase in the incidence density of CRE, CRAB and MRSA and a decrease in the incidence density of CRP and VRE. The increase in the incidence density of CRAB was 108% ( p<0.005) and MRSA was 94% ( p<0.005; Table 1 ).

Analysis by MDR pathogens in ICU units also shows an increase in the incidence density of MRSA and CRAB and also shows a decrease in the incidence density of CRE, CRP and VRE. In the ICU, the increase in the incidence density of CRAB and MRSA 42% (p=0.001) and 46.2% (p=0.040), respectively. (Table 1) 

To our knowledge this is the first Brazilian study to evaluate incidence densities of bacterial MDR infections during the COVID-19 pandemic. We found significant differences in the density incidence of MDR infections when comparing the pre-pandemic and pandemic period, especially on MRSA and CRAB infections. Our results show how the transition of a big general hospital to a COVID-19 dedicated health service alters the incidence of MDR We found an increase of 108% in HCAI by CRAB in all units and 42% in ICUs units.

Outbreaks of CRAB have been well documented in acute care hospitals, particularly among critically ill patients, and are often driven by factors that include breaches in infection control and persistent environmental contamination [21] . During the COVID-19 pandemic, inexperienced healthcare workers (HCW), reduced capacity for overall auditing practices and both intentional and unintentional changes in infection control practices likely contributed to this CRAB increase. We were unable to investigate this outbreak microbiologically. The large number of CRAB isolates, in combination with work overload, precluded a robust investigation into the causes of the CRAB increase. However, containment measures were implemented and training on the use of personal protection equipment (PPE) were performed, mainly in intensive care units, where in some COVID-19 cases the gown was used for more than one patient and discarded only at the end of the work shift. After this outbreak, we instituted the use of a second gown for patients colonized or infected by CRAB and this second gown was discarded after patient care.

Regarding the increase of 94% in HCAI by MRSA in all units and 46% in ICUs units, because of the smaller number of isolates and infrequency of MRSA in our ICUs we were able to investigate causes. MRSA infections are known to be associated with invasive devices and breach of prevention measures such as proper hand hygiene and use of inadequate PPE [18] [19] [20] . Other publications show a significant increase in bloodstream infection with an impact on mortality, with a report of 86% increase in the number of MRSA infections [22] .

We collected surveillance cultures (nasal swabs) from patients and HCW of a specific ICU where the cases were concentrated and found no secondary colonization. We were able to investigate the outbreak microbiologically since the number of isolates was smaller and the pathogen, until then infrequent and mainly in the ICUs, drew earlier attention to the increase in the number of cases.

We noted a stabilization in CRE rates and a decrease in CRP and VRE rates. A possible explanation for why some MDR rates increase while others decrease is the biological plausibility of these agents or the consumption of antimicrobials by selective pressure [23] .

Despite campaigns reinforcing the absence of antibiotic action in viral diseases it is noted that there is a trend in more antibiotic prescriptions in these situations and that it should continue in the current context, leading to a greater risk of selection of resistant microbiota, a serious contemporary problem that spreads as well as a pandemic, already with complex and serious consequences [8, 10, 12, 15] . The analysis of antimicrobial consumption is a concern of another study.

there is a tendency to prescribe macrolides in the outpatient setting, likely because of inpatient associations with better outcomes that have not been proven in outpatient settings [21] . Inpatient clinicians tend to prescribe third generation cephalosporins [24] . In a recent meta-analysis, it was noted that up to two thirds (62.4%) of patients who received some medical care because of SARS-COV-2 infection received some antibiotic, the choice was heterogeneous and dependent on the region evaluated with microbiological evidence of presumptive bacterial infection in 5% to 8% of the patients studied. [24] [25] [26] . The need to stay ahead of infection in the critically ill pushes clinicians towards a greater use of broadspectrum antimicrobials in mechanically ventilated patients due to the difficulty in distinguishing the inflammatory phase of COVID-19 with the appearance of secondary infection [8, 16] . Future studies are warranted to evaluate the changes in incidence of MDR infections during COVID-19 in Brazil with changes in antibiotic prescribing patterns.

Another consideration is that COVID-19 critically ill patients tend to have longer mechanical ventilation periods and longer hospital stays. That can lead to important sequels like pressure ulcers with secondary infections by MDR agents and other HCAI in non-ICU patients, a reasonable explanation on the MDR rise both in ICU and non-ICU settings.

Limitations of this study include its single center data and the center's focus on COVID-19 care during part of the pandemic period, which may have introduced a selection bias that limits generalizability.

Recently there is a large scientific production on COVID-19 but few publications directly assessing the changes occurring in health services. The majority of articles and reviews focus on theoretical postulations. Thus, our study shows the impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.

Our study highlights two risks of modifying standard practice to address a pandemic: 1) infection control measures and 2) antibiotic over prescription based on the difficulty in lightly.

In conclusion, COVID-19 is associated with an increase in incidence of CRAB and MRSA infections both in ICUs and non-ICUs units. Infection control teams should be aware of the risk of outbreaks from these pathogens. Strategies to reduce antimicrobial consumption in hospitalized COVID-19 patients and ensure proper PPE use may mitigate these increases.

Research is needed to explore the relationship between antimicrobial prescription patterns during COVID-19 and increases in MDR incidence.

No funding was received for this work.

this submission was not prior presented at any meeting

The authors declare no conflicts of interest. 

World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance

Mitigating the wider health effects of covid-19 pandemic response

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The Novel Coronavirus COVID-19 Outbreak: Global Implications for

Scientists alarmed at spread of Covid mutant. FT.com

How covid-19 is accelerating the threat of antimicrobial resistance

Mechanisms of Antibiotic Resistance

On the front lines of coronavirus: the Italian response to covid-19

Antimicrobial use, drugresistant infections and COVID-19

A Real-world Evaluation of a Casebased Reasoning Algorithm to Support Antimicrobial Prescribing Decisions in Acute Care

Antibiotic treatment for COVID-19 complications could fuel resistant bacteria

Could the COVID-19 pandemic aggravate antimicrobial resistance?

Surveillance Definitions for Specific Types of Infections

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 30th Informational Supplement

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Enterobacteriales Coresistant to Carbapenems and Polymyxins

Antimicrobial Development: What Can We Expect?

Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm

Multidrug-Resistant Bacterial Infections in Geriatric Hospitalized Patients before and after the COVID-19

Outbreak: Results from a Retrospective Observational Study in Two Geriatric Wards

Cluster of carbapenemase-producing Enterobacterales secondary infections during the COVID-19 crisis at a New York City hospital

Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions -New Jersey

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

Hospital-Acquired Carbapenem

Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions -New Jersey

COVID-19 and the potential longterm impact on antimicrobial resistance

Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits

Virtually Perfect? Telemedicine for Covid-19

Tackling antimicrobial resistance in the COVID-19 pandemic

Systematic research to overcome newly emerged multidrug-resistant bacteria

Medidas de Prevenção de Infecção Relacionada à Assistência à Saúde

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical microbiology and infection

Antibiotic prescribing in patients with COVID-19: rapid review and metaanalysis. Clinical microbiology and infection

Decreased Influenza Activity During the COVID-19 Pandemic -United States

MMWR Morbidity and mortality weekly report

We are grateful to all following members of Infection